Hereditary atrial fibrillation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:334OMIM:607554I48.9
Who is this for?
Show terms as
2FDA treatments4Active trials38Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary atrial fibrillation (also called familial atrial fibrillation or hereditary AF) is an inherited heart rhythm disorder where the upper chambers of the heart (the atria) beat in a fast, chaotic, and irregular way. Unlike the more common forms of atrial fibrillation that develop due to aging or other heart conditions, hereditary atrial fibrillation is caused by changes (mutations) in genes that control how electrical signals travel through the heart. These gene changes can be passed down through families. When the heart beats irregularly, it cannot pump blood as efficiently as it should. This can cause symptoms like a racing or fluttering heartbeat, dizziness, shortness of breath, and fatigue. One of the most serious risks is that blood can pool in the heart and form clots, which can travel to the brain and cause a stroke. Treatment focuses on controlling the heart rate and rhythm, preventing blood clots, and reducing stroke risk. Doctors may use medications, electrical cardioversion (a procedure to reset the heart rhythm), or catheter ablation (a minimally invasive procedure to destroy the tissue causing abnormal signals). While there is no cure, many people with hereditary atrial fibrillation can live full lives with proper medical management and monitoring.

Key symptoms:

Rapid or irregular heartbeat (palpitations)Fluttering or pounding sensation in the chestShortness of breath, especially during activityFatigue or feeling unusually tiredDizziness or lightheadednessFainting or near-fainting spellsChest discomfort or pressureReduced ability to exerciseSwelling in the legs or anklesAnxiety related to heart symptoms

Clinical phenotype terms (11)— hover any for plain English
Atrial fibrillationHP:0005110Thromboembolic strokeHP:0001727ThromboembolismHP:0001907
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Sep 2025Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure

Yonsei University — NA

TrialNOT YET RECRUITING
Jul 2025WSO BEAT STROKE Initiative

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's — NA

TrialNOT YET RECRUITING
Nov 2024PULSED AF Post-Approval Study

Medtronic Cardiac Ablation Solutions — NA

TrialRECRUITING
May 2024Cardiac Interventional ICE Imaging Trial

ICE Intelligent Healthcare Co., Ltd — NA

TrialNOT YET RECRUITING
Mar 2024Zenith LAA Occlusion System

AuriGen Medical Ltd — NA

TrialRECRUITING
Apr 2022Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation

Vanderbilt University Medical Center

TrialRECRUITING
Mar 2022Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia

Assistance Publique - Hôpitaux de Paris — PHASE3

TrialACTIVE NOT RECRUITING
Jan 2022Prospective Registry of Elderly ESUS With PFO

Asan Medical Center

TrialRECRUITING
Dec 2021Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West

University Hospital, Brest

TrialRECRUITING
Dec 2019Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Icahn School of Medicine at Mount Sinai — PHASE3

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

2 available

So-Aqueous

sotalol (IV)· AltaThera Pharmaceuticals LLC

maintenance of normal sinus rhythm in patients with history of highly symptomatic atrial fibrillation/flutter

XARELTO

RIVAROXABAN· Janssen Pharmaceuticals, Inc.■ Boxed Warning

to reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation

Clinical Trials

4 recruitingView all trials with filters →
Phase 31 trial
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Phase 3
Actively Recruiting
PI: Annetine C Gelijns, PhD (Icahn School of Medicine at Mount Sinai) · Sites: Little Rock, Arkansas; Los Angeles, California +18 more · Age: 1899 yrs
N/A2 trials
Zenith LAA Occlusion System
N/A
Actively Recruiting
PI: Felix Mahfoud (Internal Medicine and Cardiology, Saarland Univers) · Sites: Parkville, Victoria; Auckland +1 more · Age: 1899 yrs
PULSED AF Post-Approval Study
N/A
Actively Recruiting Prior treatment eligible
PI: Khaldoun Tarakji, MD (Medtronic CAS Chief Medical Officer) · Sites: Tampa, Florida; Whitesburg, Kentucky +14 more · Age: 1899 yrs
Other1 trial
Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation
Actively Recruiting
PI: M. B Shoemaker, MD (Vanderbilt University Medical Center) · Sites: Nashville, Tennessee · Age: 1599 yrs

Specialists

Showing 25 of 38View all specialists →
MM
M. B Shoemaker, MD
Specialist
PI on 1 active trial
A(
Antonio Arauz, MD (Co-Pi)
BOWLING GREEN, KY
Specialist
PI on 1 active trial
L(
Luciano A Sposato, MD, MBA (PI)
Specialist
PI on 1 active trial1 Hereditary atrial fibrillation publication
JP
Jan Hysing, MD. PhD.
Specialist
PI on 1 active trial
AP
Annetine C Gelijns, PhD
Little Rock, Arkansas
Specialist

Rare Disease Specialist

YM
Yong Cao, MD
STATE COLLEGE, PA
Specialist
PI on 1 active trial
PM
Paulus Kirchhof, MD
Specialist
PI on 1 active trial
PM
Partho Sengupta, MD
MORGANTOWN, WV
Specialist
PI on 2 active trials
SM
Sanjeev Bhavnani, MD
HARTFORD, CT
Specialist
PI on 3 active trials
AM
Andreas Metzner, MD
Specialist
PI on 1 active trial1 Hereditary atrial fibrillation publication
WM
Wenxiong Song, MD
Specialist
PI on 1 active trial1 Hereditary atrial fibrillation publication
AM
Andreas Rillig, MD
Specialist
PI on 1 active trial1 Hereditary atrial fibrillation publication
RN
Ruth Nicholson
Specialist
PI on 1 active trial4 Hereditary atrial fibrillation publications
KM
Khaldoun Tarakji, MD
Tampa, Florida
Specialist

Rare Disease Specialist

PI on 6 active trials

Treatment Centers

8 centers
⚗️ Trial Site

Massachusetts General Hospital

📍 Boston, Massachusetts

👤 Matthew Frigault, MD

👤 Janssen Research & Development, LLC Clinical Trial

⚗️ Trial Site

Stanford University

📍 Palo Alto, California

👤 Richard Neibeger, MD

⚗️ Trial Site

Emory University

📍 Atlanta, Georgia

⚗️ Trial Site

Indiana University

📍 Indianapolis, Indiana

⚗️ Trial Site

University of Southern California

📍 Los Angeles, California

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

Travel Grants

No travel grants are currently matched to Hereditary atrial fibrillation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary atrial fibrillationForum →

No community posts yet. Be the first to share your experience with Hereditary atrial fibrillation.

Start the conversation →

Latest news about Hereditary atrial fibrillation

1 articles
Clinical trialUNITERAREApr 3, 2026
New Recruiting Trial: Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
Researchers at the University of Michigan are testing whether a powder made from grapes rich in anthocyanins (natural plant compounds) can help prevent atrial f
See all news about Hereditary atrial fibrillation

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which gene mutation do I have, and how does it affect my specific treatment options?,What is my personal risk of stroke, and which blood thinner is best for me?,Should my children or siblings be tested for this condition?,Is catheter ablation a good option for me, and what are the chances it will work long-term?,Are there any activities, foods, or medications I should avoid?,How often do I need follow-up appointments and heart monitoring?,Are there any clinical trials or new treatments I should know about?

Common questions about Hereditary atrial fibrillation

What is Hereditary atrial fibrillation?

Hereditary atrial fibrillation (also called familial atrial fibrillation or hereditary AF) is an inherited heart rhythm disorder where the upper chambers of the heart (the atria) beat in a fast, chaotic, and irregular way. Unlike the more common forms of atrial fibrillation that develop due to aging or other heart conditions, hereditary atrial fibrillation is caused by changes (mutations) in genes that control how electrical signals travel through the heart. These gene changes can be passed down through families. When the heart beats irregularly, it cannot pump blood as efficiently as it shou

Are there clinical trials for Hereditary atrial fibrillation?

Yes — 4 recruiting clinical trials are currently listed for Hereditary atrial fibrillation on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Hereditary atrial fibrillation?

25 specialists and care centers treating Hereditary atrial fibrillation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.